YHYukinari Hosokawa

Yukinari Hosokawa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yukinari Hosokawa has a total of 80 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The impact of quantification and distribution of prostatic calculi by computed tomography scan on lower urinary tract symptoms: a retrospective study

    by Yoshitaka Itami, Kazuki Asada, Yuriko Hayashi, Daiki Ichii, Kota Iida, Yukinari Hosokawa, Kazuaki Hashimoto, Kiyohide Fujimoto

    Background: To evaluate the volume and distribution of prostatic calculi (PC) and to examine its relationship with the international prostate symptom score (IPSS), QOL score, overactive bladder symptom score (OABSS), and urinary flow test. Methods: We conducted a retrospective study of patients who visited the urology outpatient department of our hospital mainly for LUTS or medical examinations abnormalities. PC in computed tomography (CT) scans was quantified using a 3D image analysis system (VINCENT). We also evaluated whether the site of PC was periurethral or not, and distal or proximal. Results: A total of 318 patients with a mean age of 70.4 years and mean prostate volume of 44.2 ml were enrolled. CT revealed PC in 217 patients (68.2%). The IPSS, QOL score, and OABSS were significantly higher in the PC group than those in the non-PC group. PC volume showed a significant positive correlation with IPSS storage score (p=0.02). PC volume was an independent factor for IPSS storage score and OABSS in multiple regression analysis (p< 0.01). Among the PC groups, the periurethral calculi (PUC) group had significantly higher IPSS storage and OABSS than those in the non-PUC group (p=0.011 and p=0.007, respectively). Furthermore, among the PUC groups, when the calcification site was divided into proximal and distal sites, the IPSS and OABSS were significantly higher in the distal group than those in the proximal group (p=0.023 and p=0.010, respectively). Conclusions: Increased PC volume and PUC, especially at the distal site, were significantly associated with worsening urinary storage symptoms.

  • Open Access

    A Multicenter, Single-Arm, Prospective Trial to Evaluate Efficacy and Safety of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Carboplatin (DD-MVACarbo) Chemotherapy for Cisplatin-Ineligible Patients with Advanced Urothelial Cancer: Study Protocol of the CARBUNCLE Trial

    by Makito Miyake, Satoshi Anai, Yusuke Iemura, Kazuki Ichikawa, Tatsuki Miyamoto, Atsushi Tomioka, Masaomi Kuwada, Yoshitaka Itami, Yukinari Hosokawa, Yoshiaki Matsumura, et al.

    Unresectable, metastatic, advanced urothelial carcinoma (aUC) is an aggressive disease and is treated with platinum-containing first-line chemotherapy, followed by immune checkpoint inhibitors and antibody–drug conjugates. Response to first-line chemotherapy is a vital priority in sequential treatment strategies because a better response to first-line chemotherapy is associated with a better response to subsequent therapies. Gemcitabine plus carboplatin chemotherapy is conventionally recommended for cisplatin-ineligible patients. This multicenter, single-arm prospective trial will investigate whether dose-dense methotrexate, vinblastine, doxorubicin, and carboplatin (DD-MVACarbo) chemotherapy is superior to gemcitabine plus carboplatin chemotherapy in terms of efficacy in platinum-naïve, cisplatin-ineligible patients with aUC. After screening and registration, a total of 46 patients will be treated with this novel chemotherapy regimen. The primary endpoint is the objective response rate. The secondary endpoints include disease control rate, patient-reported outcomes, and adverse events. No evidence of this novel intervention is available as of July 2024. The results are expected to change the standard of care and improve the management of patients with aUC.


  • [Urethral Fistula Caused by an Urethrovesical Foreign Body : A Case Report].

    by Takashi Iwamoto, Yukinari Hosokawa, Kenji Otsuka, Chie Matsushita, Yoshiki Hayashi, Kenta Onishi, Kiyohide Fujimoto

    A 68-year-old man presented with the chief complaint of swelling of the penis. A pencil had been inserted into his urethra by a commercial sex worker for sexual stimulation. On a computed tomography (CT) scan, a foreign object was visible throughout the urethra and in the urinary bladder. Cystoscopy performed under spinal anesthesia showed a pencil in the urethra. We attempted removing the object endoscopically by using a Holmium laser. However, the endoscopic procedure failed and finally, we removed the object by transvesical open surgery. At the same time, suprapubic cystostomy was performed for the disorder of the urethra. An anterior urethrocutaneous fistula was formed 5 days after the operation. After removal of the urethral catheter, he was managed with only suprapubic cystostomy. Conservative management of the urethrocutaneous fistula was effective. The fistula was completely closed 26 days after the operation. He was discharged 33 days after the operation.

  • Comparison of dosimetric parameters and acute toxicity after whole-pelvicvsprostate-only volumetric-modulated arc therapy with daily image guidance for prostate cancer

    by Kentaro Ishii, Ryo Ogino, Yukinari Hosokawa, Chiaki Fujioka, Wataru Okada, Ryota Nakahara, Ryu Kawamorita, Takuhito Tada, Yoshiki Hayashi, Toshifumi Nakajima

    Objectives:To compare dosimetric parameters and acute toxicity rates between whole-pelvic (WP) and prostate-only (PO) volumetric-modulated arc therapy (VMAT) in patients with localized prostate cancer.Methods:A total of 224 consecutive patients treated with definitive VMAT to 78 Gy in 39 fractions were enrolled. Of these, 119 patients received initial WP VMAT to 46.8 Gy in 26 fractions using a simultaneous integrated boost technique, and 105 patients received PO VMAT. Image-guided radiotherapy (RT) was practiced with daily cone-beam CT.Results:The mean rectal dose, the rectal volume receiving more than 30 Gy (V30Gy), rectal V50Gy, the mean bladder dose, bladder V30Gy, and bladder V50Gy were significantly increased in the WP group (p<0.05 each); however, the rectal V70Gy did not differ between groups (p = 0.101), and the bladder V70Gy was significantly lower in the WP group (p = 0.029). The WP group experienced a significantly increased frequency of acute grade 2 diarrhea relative to the PO group (5.9% vs....


  • Open Access

    The best objective response of target lesions and the incidence of treatment-related hypertension are associated with the survival of patients with metastatic renal cell carcinoma treated with sunitinib: a Japanese retrospective study

    by Makito Miyake, Masaomi Kuwada, Shunta Hori, Yosuke Morizawa, Yoshihiro Tatsumi, Satoshi Anai, Yukinari Hosokawa, Yoshiki Hayashi, Atsushi Tomioka, Takeshi Otani, et al.

    The aim of this study is to investigate the prognostic relevance of the best objective response of metastatic target lesions during sunitinib treatment in patients with metastatic renal cell carcinoma. Radiographic analysis of the best objective response according to the Response Evaluation Criteria in Solid Tumors was assessed in 50 patients. Clinicopathological characteristics including the Heng risk classification and sunitinib-related adverse reactions were compared among four patient subgroups [complete response or partial response (CR/PR), stable disease (SD), progressive disease (PD), and those without treatment evaluation (NE)]. Kaplan–Meier and Cox proportional regression analyses of progression-free survival and overall survival were performed to identify prognostic variables. The best objective response was CR/PR in 12 (24 %) patients, SD in 22 (44 %), PD in 6 (12 %), and NE in 10 (20 %). The incidence of hypertension and hypothyroidism was associated with a better objective response. Progression-free survival was 15.0, 9.2, 6.8, and 2.2 months in the CR/PR, SD, PD, and NE groups, respectively (P = 0.0004, log-rank test), while the corresponding median overall survival was 59.7, 24.2, 17.1, and 18.1 months, respectively (P = 0.007). Multivariate analysis revealed that hazard ratios for risk of death of the SD, PD, and NE groups were 4.51 (P = 0.06), 7.93 (P = 0.02), and 4.88 (P = 0.04), respectively, as compared to the CR/PR group. Our findings suggested that the best objective response of target lesions was a prognostic marker for both progression-free survival and overall survival in sunitinib treatment. Furthermore, the incidence of sunitinib-induced hypertension was associated with a longer progression-free survival.


    • 1 March 2015
      • Vol. 61  (3) , 103-7

    [The efficacy of the use of acetic acid test in a case of local recurrence of penile carcinoma].

    by Masatake Shinohara, Yukinari Hosokawa, Kouta Iida, Kenta Onishi, Yoshitaka Itami, Yoshiki Hayashi, Kiyohide Fujimoto

    A 62-old-year male presented to our hospital with induration of the prepuce and bleeding from the glans penis that occurred during sexual intercourse. Scrape cytology was performed, which showed class V, suspected squamous cell carcinoma. Computed tomography showed no metastases, and magnetic resonance imaging revealed no invasion of the corpus spongiosum. Circumcision and resection of the glanstumor were performed. Histopathological examination revealed squamous cell carcinoma in situ. We diagnosed the case as penile carcinoma in situ (pTisN0M0, UICC stage 0, and Jackson stage I). At 6 months postoperatively, local recurrence of penile carcinoma was detected by visual inspection after 5% acetic acid staining, and tumor resection was performed. At 9 months postoperatively (after the 2nd resection), the patient has remained disease-free, with no evidence of recurrence.

    • 1 November 2014
      • Vol. 60  (11) , 555-9

    [Case of inflammatory pseudotumor occurring in the renal pelvis].

    by Kota Iida, Yukinari Hosokawa, Yoshitaka Itami, Masatake Shinohara, Yoshiki Hayashi, Kiyohide Fujimoto

    Inflammatory pseudotumor most commonly involves the lung. However, inflammatory pseudotumor has been reported in various sites in the abdomen, including the kidneys, retroperitoneum and urinary tract. We present a rare case of pathologically proven inflammatory pseudotumor in the renal pelvis. A 45-year-old woman was referred to our hospital with gross hematuria. Computed tomography demonstrated a mass around the right renal pelvocalyceal system suggestive of cystic renal cell carcinoma. Retrogradepyelography was done. Pelvic urine cytology was class III. The possibility of urothelial carcinoma could not be denied. Retroperitoneoscopic nephroureterectomy with open bladder cuff excision was performed. The histological examination revealed an inflammatory pseudotumor. She showed no evidence of disease 44 months after the operation.


    • 1 May 2014
      • Vol. 60  (5) , 231-5

    [Renal pelvic tumor with difficult radiological diagnosis : a report of two cases].

    by Masatake Shinohara, Yukinari Hosokawa, Kouta Iida, Maho Takenaga, Yoshitaka Itami, Yoshiki Hayashi, Kiyohide Fujimoto

    Case 1 : A 60-year-old man presented with right flank pain. A computed tomography (CT) scan revealed a large right renal tumor, multiple lung metastases, multiple liver metastases, and tumor thrombus of the right renal vein. These findings were strongly suggestive of renal cell carcinoma. The patient suddenly complained of dyspnea at night due to bilateral pulmonary embolism, and the patient died 11 days after onset. Needle necropsy showed that the tumors were squamous cell carcinomas of the renal pelvis. Case 2 : A 66-year-old man presented with macrohematuria. An abdominal CT scan revealed a right renal mass and liver metastasis. The differential diagnosis was between renal cell carcinoma and urothelial carcinoma. A renal biopsy revealed urothelial carcinoma of the renal pelvis. The patient died of the disease 3 months after initiation of chemotherapy with gemcitabine and cisplatin. We report these 2 cases to emphasize the importance of renal biopsy and thorough histological analysis for the determination of treatment strategies against unresectable renal tumors.

  • Open Access

    Follow-up study of unilateral renal function after nephrectomy assessed by glomerular filtration rate per functional renal volume

    by Yukinari Hosokawa, Nobumichi Tanaka, Hisakazu Mibu, Satoshi Anai, Kazumasa Torimoto, Tatsuo Yoneda, Akihide Hirayama, Katsunori Yoshida, Yoshiki Hayashi, Yoshihiko Hirao, et al.

    To evaluate the clinical usefulness of estimated glomerular filtration rate (eGFR) divided by functional renal volume (FRV) measured by three-dimensional image reconstruction (eGFR/FRV) for the prediction of functional outcomes after nephrectomy.


    • 1 October 2013
      • Vol. 59  (10) , 687-91

    [Fibrosarcoma of the spermatic cord detected with an inguinal tumor : a case report].

    by Yoshitaka Itami, Yukinari Hosokawa, Kouta Iida, Masatake Shinohara, Yoshiki Hayashi, Maho Takenaga, Kiyohide Fujimoto

    We report a case of fibrosarcoma of the spermatic cord detected with an inguinal tumor. A 45-year old man was admitted to our hospital for further examination of a right inguinal tumor. Computed tomography (CT) and magnetic resonance imaging revealed a right spermatic cord tumor,45 mm in size, and a retroperitoneal tumor in proximity to the right external iliac artery,55 mm in size. He was clinically suspected as having malignant lymphoma. As the differential diagnosis, liposarcoma and leiomyosarcoma were considered. High orchidectomy was performed for the purpose of diagnosis. The histopathological examination suggested fibrosarcoma, with a positive surgical margin. Six days after high orchidectomy, retroperitoneal tumor extirpation was performed. Total resection was difficult because the adhesion with the external iliac vein was strong. The tumor was extirpated as much as possible. The result of the histopathological examination showed fibrosarcoma. Adjuvant radiotherapy (54 Gy) was performed. After radiotherapy, local recurrence was detected by CT. He underwent systemic chemotherapy with adriamycin (60 mg/m2). After 3 courses, there was a slight reduction in tumor size. However, his general condition rapidly deteriorated with marked cachexy and he died six months from the first medical examination.